BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23574438)

  • 1. Role of environmental factors in cocaine addiction.
    Badiani A; Spagnolo PA
    Curr Pharm Des; 2013; 19(40):6996-7008. PubMed ID: 23574438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Affective and Neural Correlates of Heroin versus Cocaine Use in Addiction Are Influenced by Environmental Setting But in Opposite Directions.
    De Pirro S; Galati G; Pizzamiglio L; Badiani A
    J Neurosci; 2018 May; 38(22):5182-5195. PubMed ID: 29760180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance-specific environmental influences on drug use and drug preference in animals and humans.
    Badiani A
    Curr Opin Neurobiol; 2013 Aug; 23(4):588-96. PubMed ID: 23622777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model.
    Maremmani I; Pacini M; Perugi G; Deltito J; Akiskal H
    J Affect Disord; 2008 Feb; 106(1-2):55-61. PubMed ID: 17669508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatments for heroin and cocaine addiction.
    van den Brink W; van Ree JM
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):476-87. PubMed ID: 14636964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environment-dependent behavioral traits and experiential factors shape addiction vulnerability.
    Fouyssac M; Puaud M; Ducret E; Marti-Prats L; Vanhille N; Ansquer S; Zhang X; Belin-Rauscent A; Giuliano C; Houeto JL; Everitt BJ; Belin D
    Eur J Neurosci; 2021 Mar; 53(6):1794-1808. PubMed ID: 33332672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Out of addictions: Alcohol, or alcohol to alcohol].
    Simmat-Durand L; Vellut N; Lejeune C; Jauffret-Roustide M; Mougel S; Michel L; Planche M
    Encephale; 2017 Aug; 43(4):326-333. PubMed ID: 27372354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiments with cocaine and heroin addicts--are they predictive?
    Bye A
    Curr Opin Pharmacol; 2014 Feb; 14():74-80. PubMed ID: 24565015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting.
    Montanari C; Stendardo E; De Luca MT; Meringolo M; Contu L; Badiani A
    Psychopharmacology (Berl); 2015 Jul; 232(13):2415-24. PubMed ID: 25662790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addictions and stress: clues for cocaine pharmacotherapies.
    Picetti R; Schlussman SD; Zhou Y; Ray B; Ducat E; Yuferov V; Kreek MJ
    Curr Pharm Des; 2013; 19(40):7065-80. PubMed ID: 23574443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
    Makris N; Gasic GP; Kennedy DN; Hodge SM; Kaiser JR; Lee MJ; Kim BW; Blood AJ; Evins AE; Seidman LJ; Iosifescu DV; Lee S; Baxter C; Perlis RH; Smoller JW; Fava M; Breiter HC
    Neuron; 2008 Oct; 60(1):174-88. PubMed ID: 18940597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of social stress in addiction to psychostimulants: what we know from animal models.
    Aguilar MA; García-Pardo MP; Montagud-Romero S; Miñarro J; Do Couto BR
    Curr Pharm Des; 2013; 19(40):7009-25. PubMed ID: 23574439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cocaine addiction by environmental enrichment.
    Solinas M; Chauvet C; Thiriet N; El Rawas R; Jaber M
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17145-50. PubMed ID: 18955698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.
    Haney M
    Addict Biol; 2009 Jan; 14(1):9-21. PubMed ID: 18855806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine addiction as a neurological disorder: implications for treatment.
    Majewska MD
    NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate versus psychostimulant addiction: the differences do matter.
    Badiani A; Belin D; Epstein D; Calu D; Shaham Y
    Nat Rev Neurosci; 2011 Oct; 12(11):685-700. PubMed ID: 21971065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.